LABCORP HOLDINGS INC. Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
LABCORP HOLDINGS INC. (LH) had Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net of $557.20 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet · last filed 2026-02-24
- 2025-12-31: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $557.20M.
- 2025-06-30: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $63.50M.
- 2025-03-31: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $53.50M.
- 2024-12-31: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $869.00M; Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net as first filed $839.00M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net as first filed |
|---|---|---|
| 2025-12-31 | $557.20M 10-K · filed 2026-02-24 | |
| 2025-06-30 | $63.50M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $53.50M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $869.00M 10-K · filed 2026-02-24 | $839.00M 10-K · filed 2025-02-25 |
| 2024-09-30 | $751.20M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $293.10M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $259.20M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $671.50M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $1.16B 10-K · filed 2025-02-25 | |
| 2022-06-30 | $554.90M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $455.10M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $496.90M 10-K · filed 2022-02-25 | |
| 2017-07-31 | $745.40M 10-K · filed 2019-02-28 | $760.50M 10-K · filed 2018-02-27 |
| 2015-12-31 | $108.00M 10-K · filed 2017-02-27 | |
| 2015-02-19 | $3.07B 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |